Kato Mamoru

カトウマモル | Kato Mamoru

Affiliation and department：
Job title： Chief
Homepage URL (2)： https://www.ncc.go.jp/jp/ri/division/bioinformatics/index.html , https://www.ncc.go.jp/en/ri/division/bioinformatics/index.html

Research field (2)： Systems genomics , Biological, health, and medical informatics

Research theme for competitive and other funds (10)：

2020 - 2023 計算機シミュレーションによるがんのクローン進化・腫瘍内多様性の解明と予測への挑戦
2019 - 2022 A comprehensive genomic analysis of central nervous system germ cell tumors and generation of their cellular model
2018 - 2021 Decelopment of nect generation precision theraoy for oral cancer by single cell analysis of oral cancer CTCs
2015 - 2018 Revealing cancer-cell evolution and intra-tumor heterogeneity by single-cell genome and transcriptome analysis
2014 - 2017 Elucidation of chemoresistance of refracory cancer by single-cell gene expression analyses

Show all

Papers (82)：

Kana Shimomura, Naoko Hattori, Naoko Iida, Yukari Muranaka, Kotomi Sato, Yuichi Shiraishi, Yasuhito Arai, Natsuko Hama, Tatsuhiro Shibata, Daichi Narushima, et al. Sleeping Beauty transposon mutagenesis identified genes and pathways involved in inflammation-associated colon tumor development. Nature Communications. 2023. 14. 1
Kana Shimomura, Naoko Hattori, Naoko Iida, Yukari Muranaka, Kotomi Sato, Yuichi Shiraishi, Yasuhito Arai, Natsuko Hama, Tatsuhiro Shibata, Daichi Narushima, et al. Sleeping Beauty transposon mutagenesis identified genes and pathways involved in inflammation-associated colon tumor development. Nature communications. 2023. 14. 1. 6514-6514
Mihoko Saito-Adachi, Natsuko Hama, Yasushi Totoki, Hiromi Nakamura, Yasuhito Arai, Fumie Hosoda, Hirofumi Rokutan, Shinichi Yachida, Mamoru Kato, Akihiko Fukagawa, et al. Oncogenic structural aberration landscape in gastric cancer genomes. Nature communications. 2023. 14. 1. 3688-3688
Yasushi Totoki, Mihoko Saito-Adachi, Yuichi Shiraishi, Daisuke Komura, Hiromi Nakamura, Akihiro Suzuki, Kenji Tatsuno, Hirofumi Rokutan, Natsuko Hama, Shogo Yamamoto, et al. Multiancestry genomic and transcriptomic analysis of gastric cancer. Nature Genetics. 2023. 55. 4. 581-594
Motoo Nagane, Koichi Ichimura, Ritsuko Onuki, Daichi Narushima, Mai Honda-Kitahara, Kaishi Satomi, Arata Tomiyama, Yasuhito Arai, Tatsuhiro Shibata, Yoshitaka Narita, et al. Bevacizumab beyond Progression for Newly Diagnosed Glioblastoma (BIOMARK): Phase II Safety, Efficacy and Biomarker Study. Cancers. 2022. 14. 22

ｍore...

MISC (38)：

Tomoyuki Nakano, Yuko Matsushita, Ritsuko Onuki, Daisuke Shiokawa, Kiyomi Imamura, Terumi Horiuchi, Eita Uchida, Yui Kimura, Satoshi Ihara, Tomonari Suzuki, et al. DISSECTING INTRATUMORAL HETEROGENEITY OF CENTRAL NERVOUS SYSTEM GERM CELL TUMORS BY SINGLE-CELL RNA-SEQUENCING. NEURO-ONCOLOGY. 2020. 22. 340-341
加藤護. NCCオンコパネルと海外の遺伝子パネル. 医学のあゆみ. 2020. 275. 5. 419-423
赤塚慎也, 蒋麗, エルザワハリ・アスマ, 加藤護, 戸塚ゆ加里, 柴田龍弘, 豊國伸哉. アスベスト誘発ラット中皮腫におけるゲノム変異の特徴. 日本癌学会総会記事. 2020. 79回. PJ2-6
赤塚慎也, 蒋麗, 戸塚ゆ加里, 加藤護, エルザワハリ・アスマ, 柴田龍弘, 豊國伸哉. アスベスト誘発ラット中皮腫におけるゲノム変異の特徴解析. 日本病理学会会誌. 2020. 109. 1. 423-423
Koichi Ichimura, Motoo Nagane, Mamoru Kato, Yoshitaka Narita, Tomokazu Aoki, Shota Tanaka, Akitake Mukasa, Toshihiko Wakabayashi, Takeo Uzuka, Hideo Nakamura, et al. BIOMARK: A PHASE II STUDY OF BEVACIZUMAB BEYOND PROGRESSION FOR NEWLY DIAGNOSED GLIOBLASTOMA: SAFETY, EFFICACY AND PROSPECTIVE BIOMARKER ANALYSIS. NEURO-ONCOLOGY. 2019. 21. 12-13

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page